Abstract
From 2000 to 2009, rates of multidrug-resistant Acinetobacter baumanii increased 10-fold to 0.2 per 1,000 patient days. From 2010 to 2015, however, rates markedly declined and have stayed below 0.05 per 1,000 patient days. Herein, we present a 15-year trend analysis and discuss interventions that may have led to the decline.Infect Control Hosp Epidemiol 2018;39:608-611.
Publication types
-
Comparative Study
-
Research Support, N.I.H., Extramural
MeSH terms
-
Acinetobacter Infections / drug therapy
-
Acinetobacter Infections / epidemiology*
-
Acinetobacter Infections / prevention & control
-
Acinetobacter baumannii / drug effects
-
Acinetobacter baumannii / isolation & purification
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Child
-
Child, Preschool
-
Community-Acquired Infections / drug therapy
-
Community-Acquired Infections / epidemiology
-
Community-Acquired Infections / microbiology
-
Cross Infection / drug therapy
-
Cross Infection / epidemiology*
-
Cross Infection / microbiology*
-
Cross Infection / prevention & control
-
Drug Resistance, Multiple, Bacterial
-
Female
-
Hospitals
-
Humans
-
Infant
-
Infection Control
-
Male
-
Middle Aged
-
Risk Factors
-
Young Adult